Rhea-AI Summary
MyMD Pharmaceuticals, Inc. (MYMD) announces its common shares will begin trading on NASDAQ under the symbol 'MYMD' as of April 19th. The company focuses on developing immunotherapy assets, notably MYMD-1, aimed at treating autoimmune and age-related diseases. A Phase II trial for MYMD-1 is set to start soon, with results anticipated by year-end. The listing marks a key milestone for MyMD, aiming to enhance visibility for investors, according to President and CMO Chris Chapman.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
What is the current stock price of MyMD Pharmaceuticals (MYMD)?
MyMD Pharmaceuticals (MYMD) last closed at $1.82.
What is the market cap of MyMD Pharmaceuticals (MYMD)?
The market cap of MyMD Pharmaceuticals (MYMD) is approximately $4.3M.